DAE HWA Pharmaceutical Co., Ltd. (KOSDAQ:067080)

South Korea flag South Korea · Delayed Price · Currency is KRW
16,480
+520 (3.26%)
At close: Oct 2, 2025
3.26%
Market Cap291.13B
Revenue (ttm)148.54B
Net Income (ttm)652.26M
Shares Out17.52M
EPS (ttm)36.34
PE Ratio446.34
Forward PEn/a
Dividend150.00 (0.91%)
Ex-Dividend DateJun 27, 2025
Volume268,793
Average Volume794,510
Open16,270
Previous Close15,960
Day's Range16,050 - 16,920
52-Week Range9,960 - 24,150
Beta-0.18
RSI58.68
Earnings DateNov 11, 2025

About DAE HWA Pharmaceutical

DAE HWA Pharmaceutical Co., Ltd., a pharmaceutical company, produces and supplies pharmaceutical products in South Korea. The company offers drugs for anticancer, antibiotics, antifungal and skin ailment, antivirus, anti-allergosis, hemorrhoids, antidepressant, antiepileptic, psychotropic agent, anti respiratory, anti-inflammatory, analgesic, skeletal muscle relaxants, osteoporosis, anti-arthritis, gastro-intestinal, obesity, antispasmodic, diabetics, hypertension, hyperlipemia, antithrombotic and anticoagulant, hepatic, erectile dysfunction, u... [Read more]

Industry Pharmaceutical Preparations
Founded 1984
Employees 308
Stock Exchange KOSDAQ
Ticker Symbol 067080
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.